Literature DB >> 26916897

Expression of PTEN and its correlation with proliferation marker Ki-67 in head and neck cancer.

Malik W Ahmed1, Mahmood A Kayani1, Ghulam Shabbir2, Syed M Ali3, Wajih-Ud-Din Shinwari3, Ishrat Mahjabeen1.   

Abstract

INTRODUCTION: PTEN is part of large family of tyrosine phosphatases and has been found inactivated in a wide variety of human cancers. AIMS: In the present study we have tried to determine the association of the expression patterns of this gene with carcinogenesis.
METHODS: First, a systematic review was carried out to ascertain the importance of the PTEN gene and its role in carcinogenesis. In the second phase, a case-control study was designed using different expression analysis techniques. Expression of PTEN mRNA was analyzed using reverse transcriptase polymerase chain reaction (RT-PCR).
RESULTS: Significantly downregulated expression of PTEN was observed in patients with head and neck cancer (HNC) compared to adjacent normal-tissue controls. These results were confirmed with quantitative polymerase chain reaction (qPCR). Significant downregulation of the gene was observed in HNC patients compared to adjacent normal-tissue controls. PTEN expression was correlated with different histopathological parameters of the study cohort by Spearman's correlation coefficient and a significant negative correlation was observed with pT stage (r = -0.271*; p<0.02) and grade (r = -0.228*; p<0.02) of HNC tissues. Furthermore, the expression variations of PTEN were correlated with the expression pattern of the proliferation marker Ki-67. Significantly (p<0.008) upregulated expression of Ki-67 was observed in HNC patients compared with adjacent normal-tissue controls This upregulation of Ki-67 was confirmed at the protein level by immunohistochemistry in HNC patients. When Spearman's correlation was carried out a significant negative correlation was observed between PTEN and Ki-67 (r = -0.230*; p<0.03).
CONCLUSIONS: Our data suggest that downregulation of PTEN and overexpression of Ki-67 may contribute to the initiation and progression of HNC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26916897     DOI: 10.5301/jbm.5000196

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  4 in total

1.  Up-regulated lipocalin-2 in pediatric thyroid cancer correlated with poor clinical characteristics.

Authors:  Jun Tai; Shengcai Wang; Jie Zhang; Wentong Ge; Yuanhu Liu; Xiaodan Li; Yuwei Liu; Zhijuan Deng; Lejian He; Guoliang Wang; Xin Ni
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-04       Impact factor: 2.503

2.  Inhibition of RhoA-Subfamily GTPases Suppresses Schwann Cell Proliferation Through Regulating AKT Pathway Rather Than ROCK Pathway.

Authors:  Dandan Tan; Jinkun Wen; Lixia Li; Xianghai Wang; Changhui Qian; Mengjie Pan; Muhua Lai; Junyao Deng; Xiaofang Hu; Haowen Zhang; Jiasong Guo
Journal:  Front Cell Neurosci       Date:  2018-11-20       Impact factor: 5.505

Review 3.  SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance.

Authors:  Boshu Sun; Liangliang Xu; Wenhui Bi; Wen-Bin Ou
Journal:  Int J Mol Sci       Date:  2022-02-12       Impact factor: 5.923

4.  SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway.

Authors:  Chuanjin Liu; Haibin Wu; Yanyan Li; Liang Shen; Renchun Yu; Hongwei Yin; Ting Sun; Chunming Sun; Youxin Zhou; Ziwei Du
Journal:  J Neurooncol       Date:  2017-09-08       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.